COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,579 Articles (22,415 medRxiv, 8,164 bioRxiv)

Most recent first Previous |  Page 1276: Articles 12751-12760  | Next

N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry
Wang, D., Zhou, B., Keppel, T., Solano, M., Baudys, J., Goldstein, J., Finn, M. G., Fan, X., Chapman, A. P., Bundy, J., Woolfitt, A. R., Osman, S., Pirkle, J. L., Wentworth, D. E., Barr, J. R.
10.1101/2021.07.26.453787 — Posted: 2021-07-26
SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters
Mohandas, S., Yadav, P. D., Shete, A. A., Nyayanit, D., Sapkal, G. N., Lole, K., Gupta, N.
10.1101/2021.07.24.453631 — Posted: 2021-07-26
Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.07.25.21261093 — Posted: 2021-07-26 Discussion: Offsite
The U.S. COVID-19 Trends and Impact Survey, 2020-2021: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing and vaccination
Salomon, J. A., Reinhart, A., Bilinski, A., Chua, E. J., La Motte-Kerr, W., Rönn, M., Reitsma, M. B., Morris, K. A., LaRocca, S., Farag, T., Kreuter, F., Rosenfeld, R., Tibshirani, R.
10.1101/2021.07.24.21261076 — Posted: 2021-07-26
Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India
Arora, U., Priyadarshi, M., Katiyar, V., Soneja, M., Garg, P., Gupta, I., Bharadiya, V., Berry, P., Ghosh, T., Patel, L., Sarda, R., Garg, S., Agarwal, S., Arora, V., Ramprasad, A., Kumar, A., Garg, R. K., Kodan, P., Nischal, N., Singh, G., Jorwal, P., Kumar, A., Baitha, U., Meena, V. P., Ray, A., Sethi, P., Xess, I., Vikram, N. K., Sinha, S., Biswas, A., Thakar, A., Bhatnagar, S., Trikha, A., Wig, N.
10.1101/2021.07.24.21261040 — Posted: 2021-07-26
COVID-Q: validation of the first COVID-19 questionnaire based on patient-rated symptom gravity
Spinato, G., Fabbris, C., Conte, F., Menegaldo, A., Franz, L., Gaudioso, P., Cinetto, F., Agostini, C., Costantini, G., Boscolo Rizzo, P.
10.1101/2021.07.24.21261065 — Posted: 2021-07-26
High throughput Next-Generation Sequencing Respiratory Viral Panel: A Diagnostic and Epidemiologic Tool for SARS-CoV-2 and Other Viruses.
Sahajpal, N. S., Mondal, A. K., Njau, A., Petty, Z., Chen, J., Ananth, S., Ahluwalia, P., Williams, C., Ross, T. M., Chaubey, A., DeSantis, G., Schroth, G. P., Bahl, J., Kolhe, R.
10.1101/2021.07.24.21261046 — Posted: 2021-07-26
Epidemics of chikungunya, Zika, and COVID-19 reveal bias in case-based mapping
Bustos Carrillo, F. A., Lopez Mercado, B., Carey Monterrey, J., Collado, D., Saborio, S., Miranda, T., Barilla, C., Ojeda, S., Sanchez, N., Plazaola, M., Suazo Laguna, H., Elizondo, D., Arguello, S., Gajewski, A. M., Maier, H. E., Latta, K., Carlson, B., Coloma, J., Katzelnick, L., Sturrock, H., Balmaseda, A., Kuan, G., Gordon, A., Harris, E.
10.1101/2021.07.23.21261038 — Posted: 2021-07-26
Geographical concentration of COVID-19 cases by social determinants of health in 16 large metropolitan areas in Canada - a cross-sectional study
Xia, Y., Ma, H., Moloney, G., Garcia, H. A. V., Sirski, M., Janjua, N. Z., Vickers, D., Williamson, T., Katz, A., Yu, K., Kustra, R., Buckeridge, D. L., Brisson, M., Baral, S. D., Mishra, S., Maheu-Giroux, M.
10.1101/2021.07.23.21261039 — Posted: 2021-07-26
Breakthrough Symptomatic COVID-19 Infections Leading to Long Covid: Report from Long Covid Facebook Group Poll
Massey, D., Berrent, D., Krumholz, H.
10.1101/2021.07.23.21261030 — Posted: 2021-07-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).